IXICO PLC — AGM Information 2018

Jan 22, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5727C

IXICO plc

22 January 2018

22 January 2018

IXICO plc

("IXICO" or the "Company")

Results of AGM

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

IXICO plc Giulio Cerroni, Chief Executive Officer Susan Lowther, Chief Financial Officer	Tel: +44 20 3763 7499
Shore Capital (Nomad and Broker) Edward Mansfield/Anita Ghanekar	Tel: +44 20 7408 4090
FTI Consulting Limited (Investor Relations) Simon Conway/Mo Noonan	Tel: +44 20 3727 1000

About IXICO

IXICO is the digital technologies company serving neuroscience. Our mission is to transform the pursuit of improving brain health through the application of digital technologies to neuroscience. IXICO's specialist data analytics services are used by the global pharmaceutical industry to select participants for clinical trials, assess the safety and efficacy of new drugs in development and in post marketing surveillance. Our neurological disease focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, Parkinson's disease and our integrated digital platform encompasses the entire drug development lifecycle. It is a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable sponsors to make rapid, better informed decisions. IXICO is also collaborating with partners to develop new companion digital health products targeted at improving patient outcomes.

More information is available on www.IXICO.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFKBDDPBKDPDB